Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial

Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The record presents details for the completed Phase 2 GNbAC1 multiple-sclerosis trial, including its study design, eligibility criteria, locations, and primary outcome measure.
    Difference
    42%
    Check dated 2026-11-08T02:25:27.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:34:34.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:29:59.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-17T22:32:00.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:22:26.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with the site's header and navigation intact. Substantive trial metadata and related terms have been removed, making the study information inaccessible on this record.
    Difference
    16%
    Check dated 2026-09-19T22:03:41.000Z thumbnail image

Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.